METHOD OF TREATING NASH USING A LONG-ACTING MUTANT HUMAN FIBROBLAST GROWTH FACTOR

• 收藏
• 分享

专利权人:

TASLY BIOPHARMACEUTICALS CO.; LTD

发明人:

Jian Li,Jun Han,Xiaohui Ma,Ping Tai,Genbei Wang,Xiaodan Cao,Ruijing Huang,Yongjie Jin,Jing Li,Chen Chen,Guoyong Jia,Yuanyuan Wang

申请号：

US16520053

公开号：

US20190367574A1

申请日:

2019.07.23

申请国别(地区):

US

年份:

2019

代理人:

摘要：

The invention relates to a method of treatment comprising administering a long-acting mutant human fibroblast growth factor to a subject in need thereof. The said long-acting mutant human fibroblast growth factor is mPEG-CH2—；NαH-mFGF21, wherein mFGF21 consists of SEQ ID NO:1, and the said new use consists of a method of treating non-alcoholic steatohepatitis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/